HMOX1 and neoplasm: There was no significant difference in subcutaneous tumor volume and weight between the control and HMOX1 knockdown cell lines, whereas HMOX1 knockdown resulted in a significant bortezomib‐induced reduction in subcutaneous tumor volume and weight (Figure 5F–I).